Pooled analysis of two phase III studies provides prognostic indicators for clinical out-come after catumaxomab treatment for malignant ascites
EUROPEAN JOURNAL OF CANCER(2013)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
EUROPEAN JOURNAL OF CANCER(2013)